SLV308 -: Antiparkinsonian -: Antidepressant -: Anxiolytic -: Dopamine D2 partial agonist -: 5-HT1A agonist

被引：9
|
作者：
Feenstra, R [1 ]
Ronken, E [1 ]
Koopman, T [1 ]
de Vries, M [1 ]
McCreary, A [1 ]
Stoker, M [1 ]
van Charldorp, K [1 ]
Long, S [1 ]
van Scharrenburg, G [1 ]
机构：
[1] Solvay Pharmaceut, NL-1380 DA Weesp, Netherlands
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 02期
关键词：
D O I：
10.1358/dof.2001.026.02.608830
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：128 / 132
页数：5
相关论文
共 50 条
  • [21] Partial agonist activity of aripiprazole at D2 and 5-HT1A receptors: Evidence from in vitro binding studies
    Jordan, S
    Tadori, Y
    McQuade, R
    Yocca, F
    Kikuchi, T
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 155 - 155
  • [22] Aripiprazole is a potent partial agonist at 5-HT1A receptors
    Jordan, S
    McQuade, RD
    Koprivica, V
    Chen, R
    Tottori, K
    Kikuchi, T
    Altar, CA
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 189 - 190
  • [23] Efficacy of a 5-HT1A partial agonist in atopic dermatitis
    Kawana, S.
    Kato, Y.
    Shimoda, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S40 - S40
  • [24] Aripiprazole is a potent partial agonist at 5-HT1A receptors
    Jordan, S
    McQuade, RD
    Koprivica, V
    Chen, R
    Tottori, K
    Kikuchi, T
    Altar, CA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A17 - A17
  • [25] Clozapine:: partial agonist at dopamine D2 receptors!
    Ninan, I
    Kulkarni, SK
    PSYCHOPHARMACOLOGY, 1998, 138 (02) : 215 - 216
  • [26] Clozapine: partial agonist at dopamine D2 receptors!
    I. Ninan
    S. K. Kulkarni
    Psychopharmacology, 1998, 138 : 215 - 216
  • [27] Interaction of Dopamine D2 and 5-HT1A Receptor Partial Agonism on Antipsychotic Efficacy
    Lloyd, Haydyn
    Deng, Chao
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (02) : 192 - 193
  • [28] The effect of a 5-HT1A receptor agonist on striatal dopamine release
    Bantick, RA
    De Vries, MH
    Grasby, PM
    SYNAPSE, 2005, 57 (02) : 67 - 75
  • [29] PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions.: I.: Neurochemical effects
    Akunne, HC
    Zoski, KT
    Davis, MD
    Cooke, LW
    Meltzer, LT
    Whetzel, SZ
    Shih, YH
    Wustrow, DJ
    Wise, LD
    MacKenzie, RG
    Georgic, LM
    Heffner, TG
    Pugsley, TA
    NEUROPHARMACOLOGY, 2000, 39 (07) : 1197 - 1210
  • [30] The partial dopamine agonist pardoprunox (SLV308) administered in combination with L-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets
    Tayarani-Binazir, K.
    Jackson, M. J.
    Rose, S.
    McCreary, A. C.
    Jenner, P.
    EXPERIMENTAL NEUROLOGY, 2010, 226 (02) : 320 - 327
12345